Computerized pharmaceutical sales representative performance analysis system and method of use

• US 20030050825A1
• Filed: 09/05/2001
• Published: 03/13/2003
• Est. Priority Date: 09/05/2001
• Status: Abandoned Application

• Current Assignee: ImpactRx Incorporated (ICON PLC)
• Original Assignee: ImpactRx Incorporated (ICON PLC)
• Inventors: Gallwitz, Gerhard K., Margraf, Timothy A., Bittinger, Peter G., Gallivan, Gerald J.
• Application Number:
  US09/947,034
• Publication Number:
  US 20030050825A1
• Time in Patent Office: Days
• US Class Current: 705/10
• CPC Class Codes: G06Q 30/02 Marketing; Price estimation or determination; Fundraising
• CPC Class Codes: G06Q 30/0242 Determining effectiveness of advertisements
• CPC Class Codes: G06Q 30/0254 based on statistics
• CPC Class Codes: G06Q 30/0277 Online advertisement
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

A computerized system and method for conducting a survey of the promotional activities of sales representatives for specific pharmaceuticals of the various pharmaceutical companies. A single panel of physicians is provided to collect data regarding both (1) the promotional activities of the sales representatives whom they have encountered, and (2) the diagnosis and treatment of their patients. The data is provided into a database for analysis to evaluate any cause and effect relationship between the promotional activities of the sales representatives and the pharmaceuticals prescribed by them to their patients. of Montgomery, Commonwealth of Pennsylvania, respectively, have made a certain new and useful invention in a Computerized Pharmaceutical Sales Representative Performance Analysis System And Method Of Use of which the following is a specification.

Claims

1. A method for evaluating any causal linkage between the promotional activities of sales representatives for specific pharmaceuticals of various pharmaceutical companies and the pharmaceuticals prescribed by physicians for their patients, said method comprising:

(A) establishing a single panel of a plurality of geographically diversified prescribing physicians;

(B) collecting first data from each of said physicians regarding the promotional activities of the sales representatives whom said physicians have encountered with respect to the specific pharmaceuticals;

(C) collecting second data from each of said physicians regarding the diagnosis and treatment of the patients of said physicians with respect to said specific pharmaceuticals;

(D) providing said first and second data into a database; and

(E) analyzing said database of said first and second data to evaluate any cause and effect relationship between the promotional activities of the sales representatives and the pharmaceuticals prescribed by the physicians to their patients.

2. The method of claim 1 wherein said physicians are general practitioners, family practice practitioners and internal medicine practitioners.

3. The method of claim 1 additionally comprising:

(F) collecting third data regarding the access of said sales representatives to each of said physicians, and providing such access information into said database.

4. The method of claim 3 wherein said method additionally comprises:

(G) analyzing said database to quantify the percentage of representatives for a specific pharmaceuticals who gain access to said physicians.

5. The method of claim 1 wherein said first data from each of said physicians comprises data regarding the sales representative'"'"'s encounter with that physician, and wherein said method additionally comprises:

(F) analyzing said database to quantify the percentage of sales representatives for the specific pharmaceuticals who encounter said physicians.

6. The method of claim 5 wherein said first data also includes information regarding the nature of the encounter.

7. The method of claim 6 wherein said data about the nature of the encounter indicates if the encounter was a one-way conversation, a two-way conversation or a combination of a one-way and two-way conversation about a specific pharmaceutical or plural specific pharmaceuticals, or if the encounter did not include any reference to any specific pharmaceutical(s).

8. The method of claim 6 wherein said data about the nature of the encounter indicates whether a specific message about the pharmaceutical that is intended to be delivered by the sales representatives to the physician was, in fact, delivered to the physician.

9. The method of claim 7 wherein said data about the nature of the encounter also indicates whether a specific message about the pharmaceutical that is intended to be delivered by the sales representatives to the physician was, in fact, delivered to the physician.

10. The method of claim 1 wherein said database is provided with reference data including information regarding said specific pharmaceuticals, and which reference data is updated so as to be current.

11. The method of claim 1 wherein said database is provided with data regarding said physicians of said panel.

12. The method of claim 1 additionally comprising:

(F) utilizing hard-copy forms for collecting data regarding the access of said sales representatives to each of said physicians, and for providing such access data into said database.

13. The method of claim 1 wherein said first and second data is captured by said physicians on data entry devices selected from the group consisting of personal computers and personal digital assistants.

14. The method of claim 13 wherein said first and second data is provided electronically from said data entry devices via an electronic communication network to said database.

15. The method of claim 14 wherein said electronic communication network comprises the Internet.

16. The method of claim 1 wherein said method comprises making use computerized means for establishing said database and wherein said method additionally comprises utilizing said computerized means for:

(F) pre-processing said data into a loadable format;

(G) loading said data into first database tables;

(H) transforming field values into standard dimensional values;

(I) loading transformed records into second database tables;

(J) extracting transaction records into detailed fact tables;

(K) creating summary tables from detailed fact tables; and

(L) extracting fact and dimensional tables for data output.

17. The method of claim 13 wherein said first and second data is provided from said data entry devices via the Internet to said database and wherein the method additionally comprises utilizing hard-copy forms for collecting data regarding the access of said sales representatives to each of said physicians and providing said access data in electronic form to said database.

18. The method of claim 17 wherein said access data is provided by facsimile for inclusion in said database, wherein said method comprises making use computerized means for establishing and managing said database and wherein said method additionally comprises utilizing said computerized means for:

(F) pre-processing said data from said data entry devices and from facsimile to render said data into a loadable format;

(G) loading said data into first database tables;

(H) transforming field values into standard dimensional values;

(I) loading transformed records into second database tables;

(J) extracting transaction records into detailed fact tables;

(K) creating summary tables from detailed fact tables; and

(L) extracting fact and dimensional tables for data output.

19. The method of claim 1 additionally comprising collecting data representing the pharmaceutical company call record information and providing such call record data into said database to discern true call activity and the correlation between self-reported call activity and physician reported encounter activity.

20. The method of claim 1 additionally comprising collecting data from the physician office staff regarding access of the sales representative to the physicians, and also collecting data representing pharmaceutical company sample file record information and providing such sample file record data into said database to discern true physician office activity levels and the correlation between sample activity and physician office staff reported office activity.

21. The method of claim 1 additionally comprising collecting data representing pharmacy-level dispensed product prescription information and providing said pharmacy-level dispensed product prescription data into said database to provide a comparative analysis of the correlation between physician intended and pharmacy dispensed product prescription information.

22. The method of claim 1 additionally comprising collecting data representing patient-level disease treatment and managed care organization (M.O.) information and providing such patient-level disease treatment and managed care organization data into said database to provide a comparative analysis of the entire patient-provider-M.O. disease treatment continuum.

23. A system for evaluating any causal linkage between the promotional activities of sales representatives for specific pharmaceuticals of the various pharmaceutical companies and the pharmaceuticals prescribed by physicians for their patients, said system comprising a plurality of data entry devices, a electronic communications network and a computerized database, said plural data entry devices being arranged for use by a single panel of plural, geographically diverse prescribing physicians to collect first and second data from each of the physicians, said first data comprising information about the promotional activities of the sales representatives whom the physicians have encountered with respect to specific pharmaceuticals, said second data comprising information about the diagnosis and treatment of the patients of the physicians with respect to the specific pharmaceuticals, each of said data collection devices being arranged to be coupled to said electronic communications network to provide said data to said computerized database, said computerized database being arranged to be analyzed with respect to said first and second data to evaluate any cause and effect relationship between the promotional activities of the sales representatives and the pharmaceuticals prescribed by the physicians to their patients.

24. The system of claim 23 wherein said data entry devices are selected from the group consisting of personal computers and personal digital assistants.

25. The system of claim 23 wherein said electronic communication network comprises the Internet.

26. The system of claim 25 wherein said system is arranged to provide output data to any companies of the pharmaceutical industry regard the pharmaceuticals of their company and its competitors.

27. The system of claim 26 wherein said output data is in the form of a hard-copy report.

28. The system of claim 26 wherein said output data comprises client data extracts.

29. The system of claim 28 wherein said client data extracts are provided in hard-copy form.

30. The system of claim 26 wherein said output data is in electronic form.

31. The system of claim 30 additionally comprises a front end tool for enabling users of said front end tool for extracting selected information from said output data.

32. The system of claim 23 wherein said database is also provided with data regarding the access of the sales representatives to each of the physicians.

33. The system of claim 32 wherein system includes hard-copy forms for collecting said data regarding access of the sales representatives to each of the physicians.

34. The system of claim 33 wherein said system includes means for converting the data in said hard-copy forms to electronic signals for use in said computerized database.